THE RELATIONSHIP OF BLOOD-GLUCOSE AND HEMOGLOBIN-A LEVELS IN DIABETIC SUBJECTS

被引：9

作者：

PRENDERGAST, C ^{[1
]}

SMYTH, O ^{[1
]}

MURRAY, F ^{[1
]}

CUNNINGHAM, SK ^{[1
]}

MCKENNA, TJ ^{[1
]}

机构：

[1] ST VINCENTS HOSP,DEPT ENDOCRINOL & DIABET MELLITUS,ELM PK,DUBLIN 4,IRELAND

来源：

IRISH JOURNAL OF MEDICAL SCIENCE | 1994年 / 163卷 / 05期

关键词：

D O I：

10.1007/BF02943257

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recommendations exist that fasting plasma glucose (FPG) levels can be substituted for glycosylated haemoglobin A1 (HbA1) in Type II diabetic subjects (DM II), which have potential important financial implications. The present study was designed to expand this examination and to include Type I DM (DMI) patients and random blood glucose (RBG) values. Data were obtained from 234 DM II and 104 DM I patients, over 3 years. Correlation of HbA1 with FPG levels in DM II yielded an r value of 0.61. Correlation of HbA1 with RBG and 2 h post prandial glucose measurements yielded r values of 0.59 and 0.51 respectively, p<0.001. In DM 1, similar correlations gave r values ranging between 0.27 and 0.38, p<0.01-0.001. Thus while significant correlations exist between HbA1 and FPG and RBG measurements in both DM I and DM II, clinically applicable information on long-term diabetic control can only be achieved from glucose measurements in DM II but the correlation is not sufficiently tight to recommend substitution of plasma glucose for HbA, determinations, despite the cost advantages.

引用

页码：233 / 235

页数：3

共 16 条

[1]

Koenig R.J., Peterson C.M., Jones R.L., Saudek C., Lehrman M., Cerami A., Correlation of glucose regulation and haemoglobin Ale in diabetes mellitus, N. Engl. J. Med., 295, pp. 417-20, (1976)

[2]

Goldstein D.E., Is glycosylated haemoglobin clinically useful?, N. Engl. J. Med., 310, pp. 384-5, (1984)

[3]

Pecoraro R.E., Koepsell T.D., Chen M.S., Lipsky B.A., Balcher D.W., Inui T.S., Comparative clinical reli- ability of fasting plasma glucose in glycosylated haemoglobin in non-insulin dependent diabetes mellitus, Diabetes Care, 9, pp. 370-5, (1986)

[4]

Santiago J.V., Davis J.E., Fisher F., Haemoglobin Alc levels in a diabetes detection program, J. Clin. Endocrinol. Metab., 47, pp. 578-80, (1978)

[5]

McCance D.R., Ritchie C.M., Kennedy L., Is HbA<sub>1</sub> measurement superfluous in NIDDM?, Diabetes Care, 11, pp. 512-4, (1988)

[6]

Jovanovic L., Peterson C.M., The clinical utility of glycosylated haemoglobin, Am. J. Med., 70, pp. 331-8, (1981)

[7]

Cederholm J., Ronguist G., Wibell L., Comparison of glycosylated haemoglobin with the oral glucose tolerance test, Diabete et Metabolisme, 10, pp. 324-9, (1984)

[8]

Paisey R.B., Bradshaw P., Hartog M., Home blood glucose concentrations in maturity onset diabetes, Br. Med. J., 280, pp. 596-8, (1980)

[9]

Morria M.A., Grandis A.S., Litton J., Am. J. Obstet. Gynecol., 153, pp. 257-60, (1985)

[10]

Hermensson G., Ludrigsson J., Larsson Y., Home blood glucose monitoring in diabetic children and adolescents, Acta Paediatrica, 75, pp. 98-105, (1986)

← 1 2 →